| Primary |
| Rheumatoid Arthritis |
53.5% |
| Product Used For Unknown Indication |
8.8% |
| Psoriasis |
7.0% |
| Psoriatic Arthropathy |
5.3% |
| Hypertension |
4.9% |
| Ankylosing Spondylitis |
4.3% |
| Juvenile Arthritis |
2.9% |
| Prophylaxis |
2.4% |
| Osteoporosis |
1.9% |
| Pain |
1.9% |
| Hypothyroidism |
1.0% |
| Arthritis |
0.9% |
| Type 2 Diabetes Mellitus |
0.9% |
| Diabetes Mellitus |
0.7% |
| Juvenile Idiopathic Arthritis |
0.7% |
| Polyarthritis |
0.7% |
| Atrial Fibrillation |
0.6% |
| Graft Versus Host Disease |
0.6% |
| Hyperuricaemia |
0.5% |
| Depression |
0.5% |
|
| Pneumonia |
10.5% |
| Rheumatoid Arthritis |
7.9% |
| Breast Cancer |
7.4% |
| Pulmonary Fibrosis |
5.9% |
| Sepsis |
5.9% |
| Urinary Tract Infection |
5.9% |
| Death |
5.4% |
| Prostate Cancer |
5.1% |
| Myocardial Infarction |
4.9% |
| Pyrexia |
4.9% |
| Lung Neoplasm Malignant |
4.6% |
| Drug Ineffective |
4.1% |
| Atrial Fibrillation |
3.8% |
| Breast Cancer Female |
3.8% |
| Cellulitis |
3.8% |
| Dyspnoea |
3.6% |
| Skin Cancer |
3.3% |
| Interstitial Lung Disease |
3.1% |
| Renal Failure |
3.1% |
| Sarcoidosis |
3.1% |
|
| Secondary |
| Rheumatoid Arthritis |
48.0% |
| Drug Use For Unknown Indication |
10.9% |
| Product Used For Unknown Indication |
9.5% |
| Psoriatic Arthropathy |
6.2% |
| Psoriasis |
5.8% |
| Juvenile Arthritis |
4.0% |
| Ankylosing Spondylitis |
3.8% |
| Hypertension |
2.1% |
| Prophylaxis |
1.5% |
| Pain |
1.3% |
| Spondylitis |
1.2% |
| Immunosuppression |
1.2% |
| Osteoporosis |
1.1% |
| Behcet's Syndrome |
0.6% |
| Arthritis |
0.5% |
| Diabetes Mellitus |
0.5% |
| Crohn's Disease |
0.5% |
| Depression |
0.4% |
| Diffuse Vasculitis |
0.4% |
| Insomnia |
0.4% |
|
| Weight Decreased |
8.9% |
| Cellulitis |
7.3% |
| Breast Cancer |
6.3% |
| Pneumonia |
6.3% |
| Sepsis |
6.0% |
| Tuberculosis |
5.7% |
| Pyrexia |
5.5% |
| Septic Shock |
5.5% |
| Non-hodgkin's Lymphoma |
5.2% |
| Rectal Haemorrhage |
4.9% |
| Vomiting |
4.7% |
| Thrombocytopenia |
4.4% |
| Breast Cancer Recurrent |
4.2% |
| Staphylococcal Infection |
4.2% |
| Squamous Cell Carcinoma |
3.9% |
| Drug Ineffective |
3.6% |
| Urinary Tract Infection |
3.6% |
| Sarcoidosis |
3.4% |
| Thyroid Cancer |
3.4% |
| Basal Cell Carcinoma |
3.1% |
|
| Concomitant |
| Rheumatoid Arthritis |
32.8% |
| Drug Use For Unknown Indication |
21.6% |
| Product Used For Unknown Indication |
17.6% |
| Psoriasis |
6.0% |
| Psoriatic Arthropathy |
4.8% |
| Hypertension |
3.3% |
| Osteoporosis |
1.8% |
| Ankylosing Spondylitis |
1.7% |
| Pain |
1.5% |
| Polyarthritis |
1.1% |
| Prophylaxis |
1.0% |
| Juvenile Arthritis |
1.0% |
| Smoking Cessation Therapy |
0.9% |
| Pustular Psoriasis |
0.8% |
| Depression |
0.8% |
| Arthritis |
0.7% |
| Diabetes Mellitus |
0.7% |
| Bone Marrow Conditioning Regimen |
0.7% |
| Immunosuppression |
0.7% |
| Fibromyalgia |
0.6% |
|
| Rheumatoid Arthritis |
12.5% |
| Drug Ineffective |
11.1% |
| Vomiting |
7.7% |
| Osteoarthritis |
6.3% |
| Respiratory Failure |
6.3% |
| Weight Increased |
6.3% |
| Sepsis |
5.3% |
| Rash |
4.3% |
| Systemic Inflammatory Response Syndrome |
4.3% |
| Tremor |
4.3% |
| Pyrexia |
3.8% |
| Maternal Exposure During Pregnancy |
3.4% |
| Psoriasis |
3.4% |
| Pustular Psoriasis |
3.4% |
| Weight Decreased |
3.4% |
| Cough |
2.9% |
| Delusion |
2.9% |
| Injection Site Pain |
2.9% |
| Myocardial Infarction |
2.9% |
| Oedema Peripheral |
2.9% |
|
| Interacting |
| Rheumatoid Arthritis |
55.0% |
| Polyarthritis |
15.0% |
| Epilepsy |
10.0% |
| Psoriatic Arthropathy |
10.0% |
| Hypertension |
5.0% |
| Psoriasis |
5.0% |
|
| Weight Decreased |
30.0% |
| B-cell Lymphoma |
10.0% |
| Drug Interaction |
10.0% |
| Injection Site Warmth |
10.0% |
| Lung Neoplasm Malignant |
10.0% |
| No Reaction On Previous Exposure To Drug |
10.0% |
| Pulmonary Embolism |
10.0% |
| Schizophrenia |
10.0% |
|
